Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience

被引:21
|
作者
Naranjo-Escobar, J. [1 ,2 ]
Manzi, E. [3 ]
Posada, J. G. [4 ]
Mesa, L. [4 ]
Echeverri, G. J. [5 ]
Duran, C. [4 ]
Schweneiberg, J. [4 ]
Caicedo, L. A. [5 ]
Villegas, J. I. [5 ]
Tobon, G. J. [2 ,6 ,7 ]
机构
[1] Fdn Valle Lili, Rheumatol Unit, Cali, Colombia
[2] ICESI Univ, Sch Med, Cali, Colombia
[3] Fdn Valle Lili, Transplant Unit, Ctr Clin Res, Cali, Colombia
[4] Fdn Valle Lili, Internal Med & Nephrol Unit, Cali, Colombia
[5] Fdn Valle Lili, Abdominal Transplantat Surg, Cali, Colombia
[6] Fdn Valle Lili, Rheumatol Unit, Cali, Colombia
[7] Fdn Valle Lili, Lab Immunol, Cali, Colombia
关键词
Systemic lupus erythematosus; lupus nephritis; end-stage renal disease; kidney transplant; CLINICAL-OUTCOMES; RISK-FACTORS; ERYTHEMATOSUS; RECURRENCE; RECIPIENTS; SECONDARY;
D O I
10.1177/0961203317696591
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Lupus nephritis (LN) is one of the most frequent complications of SLE and occurs in up to 50% of cases depending on the studied population. Of these, approximately 20% progress to end-stage renal disease (ESRD), with the treatment of choice being a kidney transplant. Objective The objective of this study was to describe the clinical outcome of patients transplanted due to LN, compared with patients transplanted for other causes, in a Latin American population from the Fundacion Valle del Lili in Cali, Colombia. Methods Observational, retrospective case study with controls matched by age, sex and type of donor in a single center between 1996 and 2014. Results Sixty-five kidney transplants were performed in patients with LN and ESRD. The survival of patients with LN was 98% at 1, 10 and 15 years (p=.99). For controls by age and sex, survival was also 98% at 15 years post-transplant, and for controls by donor, the survival rate was 100% at 5 years and 98% at 15 years. Graft survival in patients with LN to 1, 5 and 15 years was 92%, 83% and 71%, respectively; for controls by age and sex, it was 90%, 84% and 64%, respectively, and for the controls by donor, it was 89%, 86% and 79%, respectively (p=.7718). There were no statistically significant differences found in the cumulative incidence of acute graft rejection in the first year, but it was found that acute rejection is a factor that relates to the loss of function of the renal graft (p=.032). Of the patients transplanted for LN, two (3.1%) experienced a recurrence of the disease. One patient died after a diagnosis of recurrence of LN due to an infection. Conclusions Kidney transplantation is a good option for patients with ESRD due to LN. In this Hispanic population, the survival of patients, graft survival, and cumulative incidence of graft rejection are not different from those of other transplanted patients. In addition, recurrence of LN was rare, showing the benefits of renal transplantation in LN patients with ESRD.
引用
收藏
页码:1157 / 1165
页数:9
相关论文
共 50 条
  • [21] End-stage Renal Disease Among Living-Kidney Donors: Single-center Experience
    Wafa, Ehab W.
    Refaie, Ayman F.
    Abbas, Tarek M.
    Fouda, Mohamed A.
    Sheashaa, Hussein A.
    Mostafa, Amani
    El Ghar, Mohamed I. Abo
    Ghoneim, Mohamed A.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (01) : 14 - 19
  • [22] Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis
    Plantinga, Laura C.
    Patzer, Rachel E.
    Drenkard, Cristina
    Kramer, Michael R.
    Klein, Mitchel
    Lim, S. Sam
    McClellan, William M.
    Pastan, Stephen O.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (04) : 571 - 581
  • [23] Renal transplantation in patients with lupus nephritis: A single-center experience
    Ghafari, A.
    Etemadi, J.
    Ardalan, M. R.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (01) : 143 - 144
  • [24] Renal transplantation in patients with lupus nephritis: A single-center experience
    Ghafari, A.
    NEPHROLOGY, 2008, 13 : A84 - A84
  • [25] Recurrent lupus nephritis after renal transplantation: A single center experience
    Kendrick, Scott A.
    Kendrick, William T.
    Cook, William J.
    Julian, Bruce A.
    Kew, Clifton E., II
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 299 - 299
  • [26] Causes of End-Stage Renal Disease in Sudan: A Single-Center Experience
    Elsharif, Mohamed Elhafiz
    Elsharif, Elham Gariballa
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (02) : 373 - 376
  • [27] Renal replacement therapy in Latin American end-stage renal disease
    Rosa-Diez, Guillermo
    Gonzalez-Bedat, Maria
    Pecoits-Filho, Roberto
    Marinovich, Sergio
    Fernandez, Sdenka
    Lugon, Jocemir
    Poblete-Badal, Hugo
    Elgueta-Miranda, Susana
    Gomez, Rafael
    Cerdas-Calderon, Manuel
    Almaguer-Lopez, Miguel
    Freire, Nelly
    Leiva-Merino, Ricardo
    Rodriguez, Gaspar
    Luna-Guerra, Jorge
    Bochicchio, Tomasso
    Garcia-Garcia, Guillermo
    Cano, Nuria
    Iron, Norman
    Cuero, Cesar
    Cuevas, Dario
    Tapia, Carlos
    Cangiano, Jose
    Rodriguez, Sandra
    Gonzalez, Haydee
    Duro-Garcia, Valter
    CLINICAL KIDNEY JOURNAL, 2014, 7 (04): : 431 - 436
  • [28] Lupus activity in lupus nephritis patients with end-stage renal disease treated with hemodialysis
    Morad, Caroline Samy
    Zaiema, Shams ElDoha Galal
    Hafez, Eman Ahmed
    Mansour, Mohammed Maher Mohammed Mohammed
    Khalil, Amr Elsayed Mohammed Abd-Allah
    Hassan, Shaymaa Gamal Arafa
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):
  • [29] Waiting for a kidney transplant: the experience of patients with end-stage renal disease in South Korea
    Chong, Hye Jin
    Kim, Hyun Kyung
    Kim, Sung Reul
    Lee, Sik
    JOURNAL OF CLINICAL NURSING, 2016, 25 (7-8) : 930 - 939
  • [30] Outcomes of Renal Transplantation After End-Stage Renal Disease Due to Diabetic Nephropathy: A Single-Center Experience
    Tokodai, K.
    Amada, N.
    Kikuchi, H.
    Haga, I.
    Takayama, T.
    Nakamura, A.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (01) : 77 - 79